|
|
|
|
|
|
 OverView
|
I have been working as an Assistant Professor at Al-Balqa Applied University in Jordan since 2024, in the Department of Medical Laboratories within the Faculty of Medical Sciences. My research focuses on investigating the molecular pathways associated with cancer, particularly the impact of nanoparticles, such as silver nanoparticles, on key biological pathways like MAPK and PI3K. I have a specific interest in regulating miRNA gene expression in cancer patients and studying the effects of hormones and chemotherapy on these genes.
I earned my Ph.D. in Clinical Biochemistry from the University of Jordan in 2018, where my dissertation focused on evaluating the pancreatic and antioxidative effects of selected branched amino acids and fatty acids in vivo and in vitro. I also obtained a Master?s degree in Biological Sciences from Mutah University, where my thesis investigated the ability of Moraxella lincolnii bacteria to degrade 3,4-dichlorobenzoic acid under optimal growth conditions.
I have extensive practical experience in laboratory techniques such as polymerase chain reaction (PCR), gel electrophoresis, genetic analysis, and flow cytometry. Additionally, I possess advanced skills in statistical analysis using software like SPSS and GraphPad Prism, which enables me to design and analyze advanced laboratory experiments.
I teach a range of university courses for undergraduate and graduate students, including clinical biochemistry, molecular biology, pathology, and histology. I have also supervised several Master?s theses on topics such as the effect of marine sponge extracts on cancer cells, the impact of nanoparticles on bacteria and cancer cells, and the study of genes associated with chronic diseases such as diabetes and liver disease.
|
|
|
|
|
|
 Research Intersets:
|
My interests focus on the molecular pathways of cancer and the impact of nanoparticles on critical cellular pathways such as MAPK and PI3K in different types of cancer.
My secondary area of interest revolves around the regulation of miRNA expression in cancer patients, with a specific emphasis on the effects of hormones and chemotherapy.
|
|
|
|
|
 Qualifications
|
| #
|
Degree
|
University
|
Specialization
|
Graduation year
|
| 1 | PHD | University of Jordan | biology | 2017 | | 2 | MASTER DEGREE | Mutah university | biology | 2011 | | 3 | BACHELOR'S DEGREE | Mutah university | biology | 2008 |
|
|
|
|
|
|
|
|
|
|
|
 Publications
|
1- Sustained Glipizide Release and Enhanced Hypoglycemia With Nano?Mesoporous SBA?15 in Diabetic Mice ,Journal of Biochemical and Molecular Toxicology, 2026,Vol. 40,no. 3.
2- Assessment of triglyceride glucose index and
triglyceride to HDL cholesterol ratio as markers
of insulin resistance defined by the Homeostatic
Model Assessment 2 in Middle Eastern adults
with excess adiposity ,Medicine and Pharmacy Reports, 2026,Vol. 99,no. 1.
3- Ononin synergistically enhances the cytotoxic
effect of doxorubicin in MDA-MB-231 triplenegative
breast cancer cell line ,Pharmacia, 2026,Vol. 73,no. -.
4- Role of Specific miRNA Expression and Nuclear Kappa B Gene Polymorphism as Potential Diagnostic Markers for Chronic Myeloid Leukemia
,Medical Principles and Practice, 2026,Vol. -,no. -.
5- Neural Network?Based
Cancer Diagnosis from
Routine Hematological
and Biochemical Data:
Performance, Target Leakage,
and Clinical Implications ,Acta Informatica Medica, 2025,Vol. 33,no. 4.
6- Co-Loaded Nanoparticles of Empagliflozin and Rutin for
Pancreatitis Prevention and Anticancer Activity ,Drug Development Research, 2025,Vol. 86,no. 6.
7- Baicalein Sensitizes Triple Negative Breast
Cancer Cells to Cisplatin by Activating
Apoptosis ,Natural Product Communications, 2025,Vol. 20,no. 8.
8- Epidemiological Insights into
Diabetes, Hypertension, and
Heart Disease: Evidence from
a Publicly Available Health
Dataset ,Medical Archives, 2025,Vol. 79,no. 4.
9- Novel Anticancer Triple Formula Based on
Aptamer-Conjugated PEGylated
Nanoliposomes ,Technology in Cancer Research & Treatment, 2025,Vol. 24,no. -.
10- Rhoifolin potentiates the anti-cancer activity
of doxorubicin in MDA-MB-231 triple-negative
breast cancer cells ,Pharmacia, 2025,Vol. 72,no. .
11- Innovative liposomal coumarin: A promising
solution for enhancing soft white cheese
quality ,plos one, 2025,Vol. ,no. .
12- Evaluation of the Synergistic Cytotoxicity of Camptothecin with Silver Nanoparticles: Potential Anti-angiogenic, Anti-inflammatory, and Antioxidant Agents
,Jordan Journal of Biological Sciences (JJBS), 2025,Vol. 18,no. 2.
13- Optimized Rutin-incorporating PEGylated Nanoliposomes as a Model with
Remarkable Selectivity Against PANC1 and MCF7 Cell Lines ,Anti-Cancer Agents in Medicinal Chemistry, 2025,Vol. 25,no. 12.
14- Therapeutic potential of marine sponges and nanoparticles: A study on siphonochalina siphonella and AgNPs ,Journal of Medicinal and Pharmaceutical Chemistry Research, 2025,Vol. 7,no. 4.
15- The combination effects of Vorinostat and Silver Nanoparticles Targeting Angiogenesis, Oxidative Stress, and Inflammation: An in vitro study
,Journal of Medicinal and Chemical Sciences, 2024,Vol. 7,no. 10.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|